Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them
“Quantitative decision-making with data rather than empirical thinking" - Certara's Modeling & Simulation technology contributes…
Certara2022 年 9 月 13 日
Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection
For the past two years, the biotech sector saw a surge of venture funding and…
Certara2022 年 8 月 30 日
3 Major Implications of New European Clinical Trial Regulations
Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…
Certara2022 年 8 月 25 日
Mind-blowing applications of QSP in drug development: Part 2
Part 2 of this blog series dives further into the June 2022 podcast with R&D…
Certara2022 年 8 月 15 日
为什么人体放射性标记质量平衡研究在临床药理学和药物开发中非常重要？
Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…
Certara2022 年 8 月 5 日
Mind-blowing applications of QSP in drug development: Part 1
R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…
Certara2022 年 8 月 4 日
How Pharmaceutical Companies Can Engage Payers Digitally
Pharmaceutical companies should seize opportunities to digitally engage with payers globally using both face-to-face and…
Certara2022 年 7 月 29 日
How the Simcyp Discovery Simulator will Accelerate Early Drug Development
Physiologically-based pharmacokinetic (PBPK) modeling is a technique used to predict the absorption, distribution, metabolism, and…
Certara2022 年 7 月 19 日
